UTHR
United Therapeutics Corporation · Healthcare
EVP and General Counsel Paul A Mahon sold $4.0M of United Therapeutics Corporation
Sold$4,000,836
$482.03Price
8,300Shares
−16%Stake
What UTHR did after the filing
- The stock from Fri, Sep 4 open, $484.33
- +12.1%
- S&P 500, same days
- −0.7%
Measured over 30 trading days, to the Oct 19 close.
Traded Thu, Sep 3. Filed Thu, Sep 3, 4:32 PM ET, after the close. Returns use the Sep 4 open and the Oct 19 close. Not investment advice.